INVEGA TRINZA: payments to doctors
Payments that named INVEGA TRINZA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $16M
- Providers
- 19,357
- Transactions
- 108,214
- Average per transaction
- $148
The per-transaction average — $148 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 19,357 providers the average total is $828, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Johnson & Johnson | $15,954,781 | 99.5% |
| Janssen Scientific Affairs, LLC | $65,239 | 0.4% |
| Janssen Research & Development, LLC | $11,286 | 0.1% |